Unité de Fabrication des Médicaments S.A (BVMT:UMED)
Tunisia · Delayed Price · Currency is TND 8.45
-0.05 (-0.59%)
At close: Oct 8, 2025
BVMT:UMED Revenue
Unité de Fabrication des Médicaments S.A had revenue of 72.32M TND in the half year ending June 30, 2025, with 18.07% growth. This brings the company's revenue in the last twelve months to 153.79M, up 9.10% year-over-year. In the year 2024, Unité de Fabrication des Médicaments S.A had annual revenue of 147.68M with 8.58% growth.
Revenue (ttm)
153.79M
Revenue Growth
+9.10%
P/S Ratio
1.77
Revenue / Employee
268.86K
Employees
572
Market Cap
272.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 147.68M | 11.67M | 8.58% |
| Dec 31, 2023 | 136.00M | 39.64M | 41.14% |
| Dec 31, 2022 | 96.36M | 11.85M | 14.02% |
| Dec 31, 2021 | 84.51M | -6.53M | -7.18% |
| Dec 31, 2020 | 91.04M | -16.16M | -15.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition